Logo image of LIMN

LIMINATUS PHARMA INC-CL A (LIMN) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:LIMN - US53271X1081 - Common Stock

0.7023 USD
-0.07 (-9.16%)
Last: 1/26/2026, 8:00:03 PM
0.71 USD
+0.01 (+1.1%)
Pre-Market: 1/27/2026, 4:51:22 AM

No Analyst data available for LIMN.

Related screens

LIMINATUS PHARMA INC-CL A / LIMN FAQ